Indeed, preliminary in vivo results from vaccination with GPC3144-152 showed an induction of tumor-specific CD8+ T cells secreting high levels of IFN-γ and granzyme B and led to growth inhibition in yolk sac tumors [71]. The gene discussed is CD8A; the disease is neoplasm.